These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8778318)

  • 1. Expression of cathepsin D in transitional cell bladder tumours.
    Lipponen PK
    J Pathol; 1996 Jan; 178(1):59-64. PubMed ID: 8778318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An immunohistochemical and prognostic evaluation of cathepsin D expression in 105 bladder carcinomas.
    Dickinson AJ; Fox SB; Newcomb PV; Persad RA; Sibley GN; Harris AL
    J Urol; 1995 Jul; 154(1):237-41. PubMed ID: 7776437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of c-myc protein is related to cell proliferation and expression of growth factor receptors in transitional cell bladder cancer.
    Lipponen PK
    J Pathol; 1995 Feb; 175(2):203-10. PubMed ID: 7738716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of CD44 standard and variant-v6 proteins in transitional cell bladder tumours and their relation to prognosis during a long-term follow-up.
    Lipponen P; Aaltoma S; Kosma VM; Ala-Opas M; Eskelinen M
    J Pathol; 1998 Oct; 186(2):157-64. PubMed ID: 9924431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications.
    Popov Z; Gil-Diez-De-Medina S; Ravery V; Hoznek A; Bastuji-Garin S; Lefrere-Belda MA; Abbou CC; Chopin DK
    Urol Oncol; 2004; 22(2):93-101. PubMed ID: 15082004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
    Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
    Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer.
    Kamai T; Takagi K; Asami H; Ito Y; Oshima H; Yoshida KI
    Br J Cancer; 2001 May; 84(9):1242-51. PubMed ID: 11336477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of p53 protein has no independent prognostic value in breast cancer.
    Pietiläinen T; Lipponen P; Aaltomaa S; Eskelinen M; Kosma VM; Syrjänen K
    J Pathol; 1995 Nov; 177(3):225-32. PubMed ID: 8551383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-inducible factor-1alpha expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma.
    Chai CY; Chen WT; Hung WC; Kang WY; Huang YC; Su YC; Yang CH
    J Clin Pathol; 2008 May; 61(5):658-64. PubMed ID: 17908805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
    Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis in bladder cancer as related to standard prognostic factors and prognosis.
    Lipponen PK; Aaltomaa S
    J Pathol; 1994 Aug; 173(4):333-9. PubMed ID: 7965393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 expression compared with other prognostic factors in OMS grade-I stage-Ta transitional cell carcinoma of the bladder.
    Casetta G; Gontero P; Russo R; Pacchioni D; Tizzani A
    Eur Urol; 1997; 32(2):229-36. PubMed ID: 9286659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 overexpression and human papillomavirus infection in transitional cell carcinoma of the urinary bladder: correlation with histological parameters.
    Tenti P; Zappatore R; Romagnoli S; Civardi E; Giunta P; Scelsi R; Stella G; Carnevali L
    J Pathol; 1996 Jan; 178(1):65-70. PubMed ID: 8778319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
    Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
    Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancer.
    Tzai TS; Tsai YS; Chow NH
    Urol Oncol; 2004; 22(2):112-8. PubMed ID: 15082007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma.
    Zigeuner R; Tsybrovskyy O; Ratschek M; Rehak P; Lipsky K; Langner C
    Urology; 2004 Jun; 63(6):1079-83. PubMed ID: 15183954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nm23-H1 protein, DNA-ploidy and S-phase fraction in relation to overall survival and disease free survival in transitional cell carcinoma of the bladder.
    Alderisio M; Cenci M; Valli C; Russo A; Bazan V; Dardanoni G; Cucciarre S; Carreca I; Macaluso MP; Tomasino RM; Vecchione A
    Anticancer Res; 1998; 18(6A):4225-30. PubMed ID: 9891471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classic prognostic factors, flow cytometric data, nuclear morphometric variables and mitotic indexes as predictors in transitional cell bladder cancer.
    Lipponen PK; Eskelinen MJ; Kiviranta J; Nordling S
    Anticancer Res; 1991; 11(2):911-6. PubMed ID: 2064350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereologically measured nuclear volume in comparison to two-dimensional nuclear morphometry, mitotic index and flow cytometry in predicting disease outcome in bladder cancer.
    Lipponen PK
    Anticancer Res; 1993; 13(2):529-32. PubMed ID: 8517668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.